704. Incidence and Patient Outcomes of S. aureus Isolates from Acute Bacterial Skin and Skin Structure Infections (ABSSSI) with High Iclaprim MIC values in Phase 3 REVIVE Trials

BACKGROUND: The incidence and outcomes of patients with S. aureus isolates with an iclaprim MIC >8 µg/mL, a concentration that is not systemically achievable, were determined among patients from two Phase 3 studies for the treatment of ABSSSI, REVIVE-1 and -2. METHODS: REVIVE-1 and REVIVE-2 studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, David B, Charrier, Cedric, Le Bras, Chloe, Hawser, Stephen, Noviello, Stephanie S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811073/
http://dx.doi.org/10.1093/ofid/ofz360.772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811073/
http://dx.doi.org/10.1093/ofid/ofz360.772

Ejemplares similares